Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HemK methyltransferase family member 1 (HEMK1) is an evolutionarily conserved protein methyltransferase that catalyzes the N(5)-glutamine methylation of the universally conserved GGQ motif in mitochondrial translation release factors, specifically MTRF1, MTRF1L, MRPL58 (a.k.a. ICT1), and MTRFR[1][3][5]. This methylation event is important for maintaining translational fidelity and efficient translation termination in mitochondria[1][3]. HEMK1 is a S-adenosyl–L–methionine (SAM)–dependent enzyme with a dual-domain architecture, localized to the mitochondrion, and shares structural similarity with bacterial PrmC[1][3]. HEMK1 also appears to have roles in cell proliferation and immunomodulation in mammals, and bacterial homologs relate to virulence pathways, implicating the enzyme in broader cellular, developmental, and pathogenic processes[1][3][5]. Current research suggests disruption of HEMK1 does not have a substantial effect on general cellular growth or mitochondrial function in standard culture, but its full physiological and pathological significance is under continued investigation[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HemK methyltransferase family member 1 (HEMK1).